The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Minireview: Primary Aldosteronism—Changing Concepts in Diagnosis and Treatment
Open accessAbstract
Primary aldosteronism affects 5–13% of patients with hypertension. Patients with hypertension and hypokalemia and most patients with treatment-resistant hypertension should undergo screening for primary aldosteronism with a plasma aldosterone concentration to plasma renin activity ratio. A high plasma aldosterone concentration to plasma renin activity ratio is a positive screening test result, a finding that warrants confirmatory testing. For those patients that want to pursue a surgical cure, the accurate distinction between the subtypes (unilateral vs. bilateral adrenal disease) of primary aldosteronism is a critical step. The subtype evaluation may require one or more tests, the first of which is imaging the adrenal glands with computed tomography, followed by selective use of adrenal venous sampling. Because of the deleterious cardiovascular effects of aldosterone, normalization of circulating aldosterone or aldosterone receptor blockade should be part of the management plan for all patients with primary aldosteronism. Unilateral laparoscopic adrenalectomy is an excellent treatment option for patients with unilateral aldosterone-producing adenoma. Bilateral idiopathic hyperaldosteronism should be treated medically. In addition, aldosterone-producing adenoma patients may be treated medically if the medical treatment includes mineralocorticoid receptor blockade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.
Conn, J. W. (1955) · PubMed · Cited by 955
Incidentally Discovered Adrenal Masses*
KLOOS, R. T., GROSS, M. D., FRANCIS, I. R., KOROBKIN, M., & SHAPIRO, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 828
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Alderman, M. H., Madhavan, S., Ooi, W. L., Cohen, H., Sealey, J. E., & Laragh, J. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241605 · Cited by 730
Remodeling of the rat right and left ventricles in experimental hypertension.
Brilla, C. G., Pick, R., Tan, L. B., Janicki, J. S., & Weber, K. T. (1990) · Circulation Research · doi:10.1161/01.res.67.6.1355 · Cited by 674
Aldosterone induces a vascular inflammatory phenotype in the rat heart
Rocha, R., Rudolph, A. E., Frierdich, G. E., Nachowiak, D. A., Kekec, B. K., Blomme, E. A. G., McMahon, E. G., & Delyani, J. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01096.2001 · Cited by 655
Vaughan, D. E., Lazos, S. A., & Tong, K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117809 · Cited by 530
HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION
Gordon, R. D., Stowasser, M., Tunny, T. J., Klemm, S. A., & Rutherford, J. C. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02519.x · Cited by 496
Fardella, C. E., Mosso, L., Gómez-Sánchez, C., Cortés, P., Soto, J., Gómez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6596 · Cited by 463
Anderson, G. H., Blakeman, N., & Streeten, D. H. P. (1994) · Journal of Hypertension · doi:10.1097/00004872-199405000-00015 · Cited by 403
Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism
Mulatero, P., Rabbia, F., Milan, A., Paglieri, C., Morello, F., Chiandussi, L., & Veglio, F. (2002) · Hypertension · doi:10.1161/01.hyp.0000038478.59760.41 · Cited by 392
Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
Weinberger, M. H., Roniker, B., Krause, S. L., & Weiss, R. J. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02957-6 · Cited by 388
Hiramatsu, K. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.12.1589 · Cited by 355
Primary Aldosteronism: Factors Associated with Normalization of Blood Pressure after Surgery
Sawka, A. M., Young, W. F., Thompson, G. B., Grant, C. S., Farley, D. R., Leibson, C., & van Heerden, J. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-4-200108210-00010 · Cited by 347
Self-citationPrevalence of Primary Aldosteronism among Asian Hypertensive Patients in Singapore1
Loh, K.-C., Koay, E. S., Khaw, M.-C., Emmanuel, S. C., & Young, W. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6752 · Cited by 345
Self-citationThree new epoxy-spirolactone derivatives: characterization in vivo and in vitro.
de Gasparo, M., Joss, U., Ramjoué, H. P., Whitebread, S. E., Haenni, H., Schenkel, L., Kraehenbuehl, C., Biollaz, M., Grob, J., & Schmidlin, J. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22580-0 · Cited by 343
Hiramatsu, K. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340130033011 · Cited by 334
Changes in Left Ventricular Anatomy and Function in Hypertension and Primary Aldosteronism
Rossi, G. P., Sacchetto, A., Visentin, P., Canali, C., Graniero, G. R., Palatini, P., & Pessina, A. C. (1996) · Hypertension · doi:10.1161/01.hyp.27.5.1039 · Cited by 328
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Diagnosis and Treatment of Primary Hyperaldosteronism
Blumenfeld, J. D., Sealey, J. E., Schlussel, Y., Vaughan, E. D., Sos, T. A., Atlas, S. A., Muller, F. B., Acevedo, R., Ulick, S., & Laragh, J. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-11-199412010-00010 · Cited by 308
Gallay, B. J., Ahmad, S., Xu, L., Toivola, B., & Davidson, R. C. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80117-7 · Cited by 304
Kerins, D. M., Hao, Q., & Vaughan, D. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118312 · Cited by 304
Fardella, C. E. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1863 · Cited by 298
Rossi, G. P. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1083 · Cited by 289
Efficacy and tolerance of spironolactone in essential hypertension
Jeunemaitre, X., Chatellier, G., Kreft-Jais, C., Charru, A., Devries, C., Plouin, P.-F., Corvol, P., & Menard, J. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91030-7 · Cited by 276
Remodeling of the Left Ventricle in Primary Aldosteronism Due to Conn’s Adenoma
Rossi, G. P., Sacchetto, A., Pavan, E., Palatini, P., Graniero, G. R., Canali, C., & Pessina, A. C. (1997) · Circulation · doi:10.1161/01.cir.95.6.1471 · Cited by 273
High prevalence of primary aldosteronism in the Tayside hypertension clinic population
Lim, P., Dow, E., Brennan, G., Jung, R., & MacDonald, T. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001013 · Cited by 269
Effect of Activation and Inhibition of the Renin-Angiotensin System on Plasma PAI-1
Brown, N. J., Agirbasli, M. A., Williams, G. H., Litchfield, W. R., & Vaughan, D. E. (1998) · Hypertension · doi:10.1161/01.hyp.32.6.965 · Cited by 269
Incidentally discovered adrenal masses
Kloos, R. T. (1995) · Endocrine Reviews · doi:10.1210/er.16.4.460 · Cited by 267
The Pathophysiology of Aldosterone in the Cardiovascular System
ROCHA, R., & FUNDER, J. W. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04415.x · Cited by 261
Secondary Hypertension in a Blood Pressure Clinic
Sinclair, A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.7.1289 · Cited by 248
Vascular Hypertrophy and Remodeling in Secondary Hypertension
Rizzoni, D., Porteri, E., Castellano, M., Bettoni, G., Muiesan, M. L., Muiesan, P., Giulini, S. M., & Agabiti-Rosei, E. (1996) · Hypertension · doi:10.1161/01.hyp.28.5.785 · Cited by 238
Magill, S. B., Raff, H., Shaker, J. L., Brickner, R. C., Knechtges, T. E., Kehoe, M. E., & Findling, J. W. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7282 · Cited by 236
Potentially high prevalence of primary aldosteronism in a primary-care population
Lim, P. O., Rodgers, P., Cardale, K., Watson, A. D., & MacDonald, T. M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)74868-6 · Cited by 228
Hyperaldosteronism: sampling the adrenal veins.
Doppman, J. L., & Gill, J. R. (1996) · Radiology · doi:10.1148/radiology.198.2.8596821 · Cited by 218
Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients
Krum, H., Nolly, H., Workman, D., He, W., Roniker, B., Krause, S., & Fakouhi, K. (2002) · Hypertension · doi:10.1161/01.hyp.0000025146.19104.fe · Cited by 210
Montori, V. M., & Young, W. F. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00013-0 · Cited by 202
Self-citationMCKENNA, T. J., SEQUEIRA, S. J., HEFFERNAN, A., CHAMBERS, J., & CUNNINGHAM, S. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-952 · Cited by 200
The Diagnosis of Primary Aldosteronism and Separation of Two Major Subtypes
Weinberger, M. H. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.18.2125 · Cited by 198
Magill, S. B. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1066 · Cited by 195
A review of the medical treatment of primary aldosteronism
Lim, P. O., Young, W. F., & MacDonald, T. M. (2001) · Journal of Hypertension · doi:10.1097/00004872-200103000-00001 · Cited by 191
Self-citationYoung, W. F., & Klee, G. G. (1988) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30425-0 · Cited by 191
Self-citationBrown, N. J., Kim, K.-S., Chen, Y.-Q., Blevins, L. S., Nadeau, J. H., Meranze, S. G., & Vaughan, D. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6305 · Cited by 182
Factors Influencing Outcome of Surgery for Primary Aldosteronism
Celen, O. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430180072015 · Cited by 179
Prevalence of Primary Aldosteronism among Asian Hypertensive Patients in Singapore
Loh, K.-C. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2854 · Cited by 179
Rossi, E. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02969-2 · Cited by 164
Tanabe, A., Naruse, M., Naruse, K., Hase, M., Yoshimoto, T., Tanaka, M., Seki, T., Demura, R., & Demura, H. (1997) · Hypertension Research · doi:10.1291/hypres.20.85 · Cited by 163
Primary Aldosteronism: A Common and Curable Form of Hypertension
Young, W. F. (1999) · Cardiology in Review · doi:10.1097/00045415-199907000-00012 · Cited by 144
Self-citationLong-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism
Sywak, M. S., & Pasieka, J. L. (2002) · British journal of surgery · doi:10.1046/j.1365-2168.2002.02261.x · Cited by 140
Hypokalemia in the Hypertensive Patient
Kaplan, N. M. (1967) · Annals of Internal Medicine · doi:10.7326/0003-4819-66-6-1079 · Cited by 138
Primary aldosteronism: Adrenal venous sampling
Young, W. F., Stanson, A. W., Grant, C. S., Thompson, G. B., & van Heerden, J. A. (1996) · Surgery · doi:10.1016/s0039-6060(96)80033-x · Cited by 135
Self-citationCardiac Damage Prevention by Eplerenone: Comparison With Low Sodium Diet or Potassium Loading
Martinez-Vasquez, D., Rocha, R., Matsumura, M., Oestreicher, E. M., Ochoa-Maya, M. R., Roubsanthisuk, W., Williams, G. H., & Adler, G. K. (2002) · Hypertension · doi:10.1161/hyp.39.2.614 · Cited by 134
Aldosterone as a Mediator in Cardiovascular Injury
Stier, C. T., Chander, P. N., & Rocha, R. (2002) · Cardiology in Review · doi:10.1097/00045415-200203000-00008 · Cited by 128
Primary aldosteronism: A common and curable form of hypertension.
Young, W. F. (1999) · PubMed · Cited by 121
Self-citationEvaluation of the Hypertensive Patient with Emphasis on Detecting Curable Causes
Gifford, R. W., Chobanian, A. V., Bartlett, A. H., Kass, E. H., Cochrane, A. L., Kark, R. M., Miall, W. E., Sackett, D. L., Cassel, J. C., Holland, W. W., et al. (1969) · The Milbank Memorial Fund Quarterly · doi:10.2307/3349261 · Cited by 108
Relations between cardiac and vascular structure in patients with primary and secondary hypertension
Rizzoni, D., Muiesan, M. L., Porteri, E., Salvetti, M., Castellano, M., Bettoni, G., Tiberio, G. A. M., Giulini, S. M., Monteduro, C., Garavelli, G., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00322-2 · Cited by 106
Left Ventricular Hypertrophy Precedes Other Target-Organ Damage in Primary Aldosteronism
Shigematsu, Y., Hamada, M., Okayama, H., Hara, Y., Hayashi, Y., Kodama, K., Kohara, K., & Hiwada, K. (1997) · Hypertension · doi:10.1161/01.hyp.29.3.723 · Cited by 102
Laparoscopic Management of Primary Hyperaldosteronism: Clinical Experience with 212 Cases
MERIA, P., Fiquet‐Kempf, B., Hermieu, J. F., Plouin, P., & DUCLOS, J. M. (2003) · The Journal of Urology · doi:10.1016/s0022-5347(05)64028-1 · Cited by 93
Cautions over the current epidemic of primary aldosteronism
Kaplan, N. M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04223-9 · Cited by 92
Primary aldosteronism: Are we diagnosing and operating on too few patients?
Gordon, R. D., Stowasser, M., & Rutherford, J. C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0033-4 · Cited by 88
Young, W. F. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04413.x · Cited by 85
Self-citationScreening for primary aldosteronism with a logistic multivariate discriminant analysis*
Rossi, G. P., Rossi, E., Pavan, E., Rosati, N., Zecchel, R., Semplicini, A., Perazzoli, F., & Pessina, A. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00608.x · Cited by 83
Sawathiparnich, P., Kumar, S., Vaughan, D. E., & Brown, N. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.7980 · Cited by 82
The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977-1981.
Andersen, G. S., Toftdahl, D. B., Lund, J., Strandgaard, S., & Nielsen, P. E. (1988) · PubMed · Cited by 81
IS ALDOSTERONE/RENIN RATIO USEFUL TO SCREEN A HYPERTENSIVE POPULATION FOR PRIMARY ALDOSTERONISM?
Hamlet, S. M., Tunny, T. J., Woodland, E., & Gordon, R. D. (1985) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1985.tb02641.x · Cited by 71
Primary Hyperaldosteronism in the Era of Laparoscopic Adrenalectomy
Rossi, H., Kim, A., & Prinz, R. A. (2002) · The American Surgeon · doi:10.1177/000313480206800307 · Cited by 68
Diagnostic Value of the Post-Captopril Test in Primary Aldosteronism
Castro, O. L., Yu, X., & Kem, D. C. (2002) · Hypertension · doi:10.1161/01.hyp.0000014324.68506.ca · Cited by 62
Brown, N. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.336 · Cited by 61
Prevalence of Adrenal and Extra-adrenal Conn Syndrome in Hypertensive Patients
Abdelhamid, S., Müller-Lobeck, H., Pahl, S., Remberger, K., Bönhof, J. A., Walb, D., & Röckel, A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440100086010 · Cited by 56
Clinical implications of primary aldosteronism with resistant hypertension.
Bravo, E. L., Fouad-Tarazi, F. M., Tarazi, R. C., Pohl, M. A., Gifford, R. W., & Vidt, D. G. (1988) · Hypertension · doi:10.1161/01.hyp.11.2_pt_2.i207 · Cited by 55
Rationale for the Use of Aldosterone Antagonists in Congestive Heart Failure
Rocha, R., & Williams, G. H. (2002) · Drugs · doi:10.2165/00003495-200262050-00001 · Cited by 54
New Genetic Insights in Familial Hyperaldosteronism
Jackson, R. V., Lafferty, A., Torpy, D. J., & Stratakis, C. A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04414.x · Cited by 54
Yoshihara, F. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00031-3 · Cited by 43
Primary aldosteronism, a common entity? the myth persists
Padfield, P. L. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001321 · Cited by 41
Renin-Independent hypermineralocorticoidism
Young, W. F., & Hogan, M. J. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(94)90090-6 · Cited by 39
Self-citationIgnatowska-Switalska, H., Chodakowska, J., Januszewicź, W., Feltynowski, T., Adamczyk, M., & Lewandowski, J. (1997) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000444 · Cited by 31
Goldkorn, R., Yurenev, A. P., Blumenfeld, J. D., Fishman, D., & Devereux, R. B. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02331-7 · Cited by 30
Screening of a population of young hypertensives for primary hyperaldosteronism.
Kumar, A., Lall, S. B., Ammini, A. C., et al. (1994) · PubMed · Cited by 27
Functional tests for primary aldosteronism: Value of captopril suppression
Racine, M.-C., Douville, P., & Lebel, M. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0014-5 · Cited by 16
Establishing a diagnosis of primary hyperaldosteronism
Moneva, M. H., & Gómez-Sánchez, C. E. (2001) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200106000-00004 · Cited by 14
Cited by
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Self-citationFunder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
Self-citationEvidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Metadata
- Authors
- Young, W. F.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2003-06-01
- Volume
- 144
- Issue
- 6
- Pages
- 2208-2213
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2106508298
- Cited by
- 376
- References
- 83
- FWCI
- 18.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.